Navigation Links
Antibiotic might fight HIV-induced neurological problems

By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in the body.

Five monkeys infected with simian immunodeficiency virus (SIV), a very close relative of HIV, and treated with minocycline had less damage to brain cells, less brain inflammation, and less virus in the central nervous system than six infected monkeys that received no treatment, the researchers report in the April 27 issue of the Journal of the American Medical Association.

"In people, antiretroviral treatments do a great job of controlling HIV in blood, but most of the drugs don't cross the blood-brain barrier very well," says Christine Zink, D.V.M., Ph.D., professor of comparative medicine at the Johns Hopkins University School of Medicine. "As a result, even though the infection seems to be controlled, it may still cause damage in the brain. And because people are living with HIV longer than ever, the prevalence of neurological damage is increasing. Currently, there's no drug to treat it directly."

In use for more than 30 years, minocycline was specifically designed to cross the blood-brain barrier, the biological "wall" that limits what can pass from the blood into the brain. Other researchers have reported that this antibiotic can protect brain cells in animal models of other diseases -- multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, stroke and more. The drug is being tested in early clinical trials for some non-HIV-related conditions.

"Last year we discovered that SIV triggers some of the same biological pathways of cell death and inflammation as these other diseases," says Sheila Barber, Ph.D., assistant professor of comparative medicine. "Testing minocycline in our animal model of HIV infection was really a logical next step."
'"/>

Source:Johns Hopkins


Page: 1 2 3

Related biology news :

1. Antibiotic Resistant Bacterium Uses Sonar-like Strategy to “See?Enemies or Prey
2. New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal
3. To Stop Evolution: New Way Of Fighting Antibiotic Resistance Demonstrated By Scripps Scientists
4. Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips
5. Use of Antibiotics for Acne May Increase Risk of Common Illness
6. Large-scale Computer Simulations Reveal New Insights Into Antibiotic Resistance
7. Antibiotic treats lymphoma of the eye
8. Antibiotic inhibits cancer gene activity
9. Newly discovered pathway might help in design of cancer drugs
10. Compound might defeat African sleeping sickness, clinical trial beginning this month
11. Stem cells electric abilities might help their safe clinical use

Post Your Comments:
(Date:11/24/2009)...(November 24, 2009) New research on bacterial com...ems reveals predictable temporal patterns, suggest... markers for monitoring climate change in the pola...Proceedings of the National Academy of Sciences E...the six rivers shifted synchronously over time, co...
(Date:11/23/2009)...esearch presents strong evidence that the "synergi...r traffic-related pollution and indoor endotoxin c...e other exposure alone. , Environmental health...ollege of Medicine have shown that children expose... and indoor endotoxin during early life are six ti...
(Date:11/23/2009)...Mass. November 23, 2009 Applied mathematicians d...ta lancifolia ), a characteristic long leaf with a...ples along the edges. The simple cause of the lily... bending during differential growthwas revealed by...m ribbons. , Haiyi Liang, a postdoctoral student...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 1WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 1Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 3Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 4Thoratec Presentation at Canaccord Adams Conference to be Webcast 6116 1
...(BRONX, NY) Scientists at Albert Einstein College...heir revolutionary new drug-delivery system with a... deadly drug-resistant staph infections in mice. T...sion of the Journal of Investigative Dermatology ...jority of superficial and invasive skin infections...
...ussell A. Mittermeier, the president of Conservati...ty conservation, has received the Roger Tory Peter...ry. , Mittermeier is a renowned field biologist a...an 500 scientific and popular articles, along with...ecies new to science, had seven others named after...
... Calif.) Scientists at UC Santa Barbara have made...human embryonic stem cells function. , They expla... will renew, or will transform to become part of a...y. The study is reported in the May 1 issue of the... bodes well for cancer research, since tumor stem ...
Other Biology News:New technology shows promise against resistant staph infections 2New technology shows promise against resistant staph infections 3Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3
(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc...allowedthepatentapplicationfor,itsnano-particleora...ighlyefficientapproachtoincorporatepeptidesor,prot...veryofdrugs,otherwiseadministeredasinjections.NODt...anymacromoleculardrugssuchasinsulin,interferon,gr...
(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannoun...A)hasapprovedthe,investigationalnewdrugapplication...einsulinformulationtotreatdiabetes.ThisIND,approva...y. , Diabetesisadisordercharacteristicofhighb...abetesoftenresultinseveremicro-and,macro-vasculard...
(Date:11/24/2009)... The FBI recently approved the Promega...rticipating in or generating DNA records for the N... Madison, WI USA (PRWEB) -- The FBI recently app...r use by laboratories participating in, or generat... (NDIS). NDIS currently contains more than seven m...
(Date:11/24/2009)...NTURE:HTL , TORONTO,Nov.24/PRNewswire-FirstCa...apitalInc.,aleadingproviderofadvancedlasersystemsa...nicmarkets,todayreportedoperationalandfinancialres...32009Highlights,-Revenuewas$1.46millioncomparedwi...rcentcomparedwith66.1percentinQ3,2008,-Netlossredu...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...nthera Pharmaceuticals,Inc., a privately held biop... drugs, announced today that Anthera scientists an...ladib (A-002) clinical and,pre-clinical programs a...iology (ATVB) Annual Conference in Atlanta, Georgi... Phase II trials in Varespladib for the,treatment ...
Other Biology Technology:REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2BrainCells Inc. Expands Series B Financing to $50 Million 2Anthera Presents Data on Varespladib at ATVB Meeting 2
5x MONO-GOAT POLY C'GATE DILUENT from AbD Serotec
ANTIGEN-DOWN ASSAY DILUENT from AbD Serotec
Rabbit Anti-HALOPERIDOL Polyclonal Antibody, Unconjugated from AbD Serotec
TMB PLUS DILUENT from AbD Serotec
Biology Products: